跳至主要内容
临床试验/NCT05179486
NCT05179486招募中不适用

Molecular Epidemiology of Biliary Tree Cancers

M.D. Anderson Cancer Center1 个研究点 分布在 1 个国家目标入组 1,500 人开始时间: 2017年9月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
1,500
试验地点
1
主要终点
Significant factors that may contribute to the etiology of biliary tree cancer

研究概览

简要总结

This study is to learn if certain risk factors (environmental, viral, behavioral, medical, and dietary), tumor markers, and genetic changes can predict the development and outcome of biliary tree cancers. Establishing biomarkers models from patients may help doctors to further understand how biliary tree cancer is affected by different treatments, and why some people's cancer responds differently than others.

详细描述

PRIMARY OBJECTIVES:

I. To identify significant factors that may contribute to the etiology of biliary tree cancer.

II. To identify novel genetic loci that predispose to gallbladder cancers (GBC) and cholangiocarcinoma (CGC) diagnosis.

EXPLORATORY AND CORRELATIVE OBJECTIVES:

I. To use the collected blood and tissue materials for exploratory analysis to identify markers that predict prognosis of biliary tree cancers.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Pathologically or radiologically confirmed diagnosis of CGC or GBC
  • With or without prior radiation or chemotherapy
  • All United States of America (USA) and non USA residents
  • No age, gender, or racial restriction
  • Healthy control with no current or history of cancer
  • Healthy controls are USA and non USA residents
  • Healthy controls are matched to the cases in age (5 years), gender, and race
  • Healthy controls are friends and spouses of patients with other than gastro-intestinal (GI) cancers
  • Chronic Liver Disease (CLD) controls with no current or history of cancer
  • CLD controls are USA and non USA residents
  • CLD controls are frequency matched to CGC cases by age (5 years), gender, and race
  • CLD controls are patients are diagnosed with or without liver biopsy (core or fine needle aspiration)
  • CLD controls must not have evidence liver cancer diagnosis by computed tomography (CT) or magnetic resonance imaging (MRI)

排除标准

  • 未提供

研究组 & 干预措施

Observational (biospecimen collection, questionnaire)

Participants complete a questionnaire over 20 minutes. Participants also undergo collection of blood and leftover tissue samples.

干预措施: Biospecimen Collection (Procedure)

Observational (biospecimen collection, questionnaire)

Participants complete a questionnaire over 20 minutes. Participants also undergo collection of blood and leftover tissue samples.

干预措施: Questionnaire Administration (Other)

结局指标

主要结局

Significant factors that may contribute to the etiology of biliary tree cancer

时间窗: through study completion, an average of 1 year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验